Customer Testimonials

Discover the ProFound impact our AI technologies are making on our customers' facilities and patients

Expert insights today. ProFound performance tomorrow.

ProFound AI

Joshua A. Nepute, MD, Radiologist, IU Health Frankfort, IU Health Arnett, IU Health White Memorial“For radiologists who may not have as much experience with DBT, ProFound AI is a great tool, as it can help ensure they’re being thorough and adequately going through every single image slice. For radiologists who have more experience with DBT, ProFound AI provides additional confirmation and clinical confidence to ensure we’re doing a good job for our patients.”“We saw our volume of mammography screenings decrease significantly during the pandemic however, since this past spring, our volume has skyrocketed. We are at least 10% above our pre-pandemic levels at this time, which has led to feelings of burnout by many of our radiologists, but ProFound AI has been a reliable backup for our team, as it helps to ensure we’re performing at an optimum level and calling back only those patients who need additional imaging.” Sally Grady, Director,
Kettering Health Breast Centers, Kettering Health
“We recently updated our breast screening technology at our facility, and ProFound AI is the icing on the cake. We looked at other AI technologies, but have ultimately found them to be like smoke and mirrors compared to ProFound AI. A game-changing technology, ProFound AI has empowered us to offer world-class, personalized patient care. It is light years ahead of other technologies, which simply cannot measure up. I believe that patients without access to ProFound AI are at a disservice. It has helped make our breast screening program one of the best – not only in the state, but also the world.”
Diana James, MD, PhD, Radiologist, Director of Breast Imaging at Jefferson Radiology, Hartford, CT"We began the implementation of ProFound AI at the end of 2019 and completed the rollout in the middle of the pandemic, in mid-2020. Just before that time, in mid-2019, we converted our practice to 100% tomosynthesis. We are typically a very high-volume practice reading more than 50,000 screening mammograms per year, and the addition of a ‘second reader’ via ProFound AI helped our radiologists absorb our increased workload. We paused our screening mammogram program per SBI recommendations during the beginning of the pandemic, but were quickly back to full plus volume by August 2020. ProFound AI helped us to read those cases quickly with the confidence that we were not missing cancers.”Angela Fried, MD,
Director of Breast Imaging, SimonMed Imaging
“After a year of using it, I’ve come to an eye-opening realization: ProFound AI is looking at things that we clinicians don’t necessarily recognize as signs of cancer. For example, the technology flagged a few cases last year that didn’t appear visibly as signs of cancer at the time, but when the patient returned this year, there’s definitely a cancer there. We’ve really gotten to trust it, and I am hoping that more of those subtle, obscured lesions will be picked up earlier because of this.”
Mark Traill, MD, University of Michigan Metro Health“ProFound AI offers a triple win: it helps radiologists detect more cancers, with fewer unnecessary callbacks, and in less than half the time. This technology is poised to transform breast cancer detection and improve patient lives in the years ahead. I would not send a loved one to a mammography center that didn't have ProFound AI, and there is no way, having experienced the functionality of the software, that I would ever read another tomo study without it.”“In the face of COVID-19, improving accuracy and efficiency for breast cancer screening is now more essential than ever. Using this leading-edge technology, radiologists have the ability to review prior year mammograms and prioritize which patients should not delay breast cancer screening based on the technology’s unique Case Score, which represents a relative level of suspicion for the case containing potentially cancerous findings that may require further workup. It is clinically proven to help radiologists significantly increase their productivity. ProFound AI can also reduce the rate of false positives, which are not only stressful for patients, but also place a significant additional burden on providers. Clinicians using ProFound AI will be very happy they have such a sophisticated tool helping them better position their screening programs’ recovery from this unprecedented global disruption.” Matt Dewey, Chief Information Officer, Wake Radiology“As technology is advancing and becoming a more integral part of our day-to-day workflow, partnering with organizations that provide a clear advantage in AI technologies, like iCAD, has been a critical focus for our facility in recent years. We have done a thorough evaluation of all of the other available AI technologies for breast imaging, but ultimately we found ProFound AI to be the best solution. With its multi-vendor flexibility, ProFound AI seamlessly integrated into our system and clinical workflow.”Ahuva Grubstain, MD,
Head of Breast Imaging Unit, Department of Imaging, Rabin Medical Center, Hasharon, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
“We can see the percentage rating of each tumor on the screen, which aids in determining if a suspicious finding needs further workup. The software shortens radiologists’ reading times and enables quick and safe decision-making that helps us avoid unnecessary recalls and tests for patients. iCAD has developed an excellent high-level technology. As a radiologist, I can say that this is the first AI product I have used that enhances my workflow and I trust the results.”
Emily F. Conant, MD, Division Chief of Breast Imaging at the University of Pennsylvania Medical Center“Our research adds to the growing body of evidence demonstrating the potential value that AI may offer in the clinical setting. Not only may AI algorithms help increase radiologists’ confidence in interpreting DBT studies, it may also help improve reading efficiency. Our retrospective study shows that AI has the potential to correctly identify a third of DBT screening exams as having no malignancy or an extremely low likelihood of malignancy. This AI-triaging could help radiologists determine which cases may need more intensive analysis.”Dr. Axel Gräwingholt, Radiologie am Theater, Paderborn, Germany“ProFound AI as a clinical tool for radiologists has the potential to reduce interval cancer rates by detecting cancers that are already present in the screening round but are perhaps undetected or missed by the readers. Using this technology at the screening level could limit the number of false negatives and help to detect a large proportion of the minimal sign cancers, which could ensure earlier treatment and better chances of recovery for these women.”“This leading-edge technology not only improves radiologist confidence, even while reading complicated datasets, such as those with dense breasts, but also it offers increased sensitivity and specificity, which helps physicians find more cancers, while reducing recall rates for non-cancer cases. As clinicians struggle with the aftermath of COVID19, this technology is uniquely positioned to help address newfound challenges they are beginning to encounter.”“It is currently a prime time for clinicians to leverage the latest technologies, such as ProFound AI, which can help us navigate emerging challenges following this pandemic.”“iCAD’s ProFound AI™ solution has had a significant impact on our workflow. We are able to immediately react if we see something suspicious in a scan alleviating anxiety for our patients. Using the solution will allow us to expand DBT beyond diagnosis because it enables our radiologists to read as many tomosynthesis cases as we currently read with 2D mammography. I consider ProFound AI to be one of the greatest tools in modern radiology.”Neesha Patel, MD,
Director of Breast Imaging and Residency, and Clerkship Academic Director, Kings County Hospital
“ProFound AI provides added confidence – like someone looking over your shoulder- so I know I’m not the only one looking at these images.”
Dr. Harold Tanenbaum, MD, DABR, MBA, Marine Park Radiology, Brooklyn, NY“iCAD’s ProFound AI for DBT offers a quantum improvement in terms of our efficiency, enabling us to focus on abnormal findings, while reducing the rate of false positives. This is a vital tool for our practice that allows radiologists to zero-in on questionable areas, while reducing reading time and improving our overall confidence in the results.”Kathy Schilling,
MD and Radiologist, Boca Raton Regional Hospital
“We recently adopted iCAD’s ProFound AI, which has provided a great deal of assistance in mammography decisions. ProFound AI uses artificial intelligence to rapidly and accurately analyze patients’ digital breast tomosynthesis images, producing a unique and quantifiable Certainty of Finding score for the patients’ overall case.”
Meghan Musser, DO, Medical Director for Breast Imaging at Kettering Health“We have had ProFound AI for about two years now, and the way we utilize it has grown as we’ve learned to trust the technology more. Other AI technologies simply do not deliver the level of performance, speed and accuracy that ProFound AI offers. Additionally, a unique value of ProFound AI is its ability to detect small or subtle lesions, such as invasive lobular cancers (ILCs). I believe that every woman deserves to have access to this technology, as it can be a critical tool in overcoming healthcare disparities. ProFound AI is an integral part of our workflow that is enhancing our ability to personalize breast cancer screening, and I am so happy that this technology is now available to every patient across our network of facilities.”“Other AI technologies simply do not deliver the level of performance, speed and accuracy that ProFound AI offers. Additionally, a unique value of ProFound AI is its ability to detect small or subtle lesions, such as invasive lobular cancers. I believe that every woman deserves to have access to this technology, as it can be a critical tool in overcoming healthcare disparities. ProFound AI is an integral part of our workflow that is enhancing our ability to personalize breast cancer screening, and I am so happy that this technology is now available to every patient across our network of facilities.”Gabriele Pedicelli, MD, Wooster Community Hospital“Adopting ProFound AI was straightforward. It increases our comfort level knowing that the technology is reading every image, or slice, and it’s reassuring knowing that this technology will help us not miss a cancer. I typically will read the images without ProFound AI first, just to get a gut impression of the case, but when I turn ProFound AI on, it gives me added peace of mind knowing that the technology will alert me to look at certain images more closely.”“ProFound AI significantly reduces the time it takes to review 3D tomo datasets, thus reducing the amount of time needed between patients. The technology allows us to fully harness the advantages our 3D mammography system offers and improves our overall efficiency, which allows us to see more patients throughout the day within the same timeframe.”“Currently, dense breasts are considered a risk factor because dense breast tissue masks cancerous tissue on mammography images. ProFound AI not only helps us to review cases with fatty tissue, we see an even greater benefit for those women with dense breasts. Before ProFound AI, I might have read a case with dense breasts and thought ‘Let’s call them back in 6 months or a year,’ but with ProFound AI, we can more easily tell whether we should be doing another examination or biopsy. In fact, there have been two recent cases with dense breasts in a short period of time where ProFound AI helped us make the decision for a follow up, and they both turned out to be cancers.”“I would certainly recommend ProFound AI to other radiologists and imaging centers. Based on my experience reading mammography, I typically feel comfortable making the call of whether it is negative or positive, but the added confidence of calling something negative is the most significant advantage this technology offers to patients.” David Harrison, MBT, RT (R) (N), Director of Imaging Services, Wooster Community Hospital“Adopting ProFound AI was a seamless process that offered immediate benefits to our radiologists and patients, and we have gained additional efficiencies since then.”Elena Cauzza, MD,
Radiologist at Radiomedica and xDonna, a mammography and breast diagnosis center in Bellinzona, Switzerland
“Breast cancer is the most common cancer among women; however, the chances of survival are constantly increasing, especially thanks to technological advances in medical imaging that are improving screening performances. ProFound AI is fully in line with this desire to constantly improve radiologists’ abilities to detect breast cancer as early as possible. This is why I chose to install the new generation of the ProFound AI solution in my medical imaging center dedicated to breast imaging, in order to offer my patients the best possible care.”
Patrick Toubiana, MD, Radiologist, President and Co-Founder at the C.S.E. Centre Imagerie Médicale Numérique, Paris, France“When breast cancer is diagnosed early, survival after treatment is excellent, over 90% in some countries. At C.S.E., we have been using ProFound AI for 2D Mammography and DBT for several years, during which we have seen iCAD's constant commitment to improve performance in terms of both sensitivity and specificity as new versions are released.”Lisa Sheppard, MD, PINK Breast Center“As soon as we implemented ProFound AI, we started using it on all of our DBT breast cancer screenings. It greatly improved our workflow and enabled us to get back to rapid reads and offered the opportunity to provide results for patients in real-time.”“This technology has made a tremendous impact on patient care at PINK Breast Center. It helped to ensure that the biopsies we perform are more likely to be cancer, and we also now have fewer false positives and callbacks. It also helps to improve our confidence while reading DBT, even with complicated cases. For example, when you have a case that’s extra dense or has a lot of nodules or calcifications, ProFound AI allows us to read it with a higher level of confidence and make better decisions for the patients.”“It was very exciting when I learned that ProFound AI for DBT was FDA-cleared. I couldn’t wait to jump on the bandwagon to start using it. We were the first in Northern and Central New Jersey to adopt this technology – it was just another example of our practice striving to bring the best possible technology to enhance our patient care.”“When ProFound AI highlights an area, we know it’s something to investigate. It’s much more selective than other CAD technologies and offers a remarkable improvement in terms of the focus. We know it works because we’re seeing more of our biopsies actually turn out to be cancer. This technology is fabulous, and it really makes a difference. AI coupled with the physician is where medicine is going to go. I don’t think AI could ever replace a physician, but it certainly enhances the physician and ensures a more accurate read for the patient.”“The initial investment in this technology was insignificant compared to the benefits it offers to our patients. There is tremendous value in being able to confidently tell my patients, ‘I read your mammogram today and it is negative, but I also want to reassure you, ProFound AI agrees and found you are negative.’ This technology really helps to put both me and my patients at ease.”

ProFound AI Risk

Per Hall, MD, Professor/Senior Physician, Karolinska Institutet“This leading-edge algorithm was designed to provide physicians with crucial information about a woman’s short-term risk of being diagnosed with breast cancer, so that they may further personalize her screening and surveillance plan. This may include screening frequency adjustment, supplemental imaging, genetic testing and/or risk reduction strategies. Ultimately, the goal of this technology is to enhance efficiency for clinicians and improve outcomes for patients.”“The ProFound AI Risk model performs better than any other current model. The model is a short-term risk model which is an advantage in the screening setting, builds heavily on analyses of mammograms, is easy and inexpensive to implement and has little requirement of staff and systems to manage the data. Further, the risk model was also tested using other variables, such as lifestyle factors and genetic determinants, which may be added to the iCAD product in the future.”“Models that accurately predict an individual woman’s risk of developing breast cancer are paramount to transitioning from age-based screening to risk-based screening. Most current risk models are population-based and focus on lifetime or long-term risk. Our research using the iCAD AI technology has shown that by simply using the information available in the mammogram images, we can more accurately stratify women based on short-term risk. Understanding short-term risk will open the door to new paradigms in both the prevention and treatment of breast cancer.”“The ProFound AI Risk model is a validated short-term risk model that provides clinically relevant data about patients’ individual risk of developing cancer between screenings. Our study data show that the ProFound AI Risk model offers significantly superior performance compared to any other current model.”Dr. Axel Gräwingholt, Radiologie am Theater, Paderborn, Germany“This leading-edge algorithm was designed to provide physicians with crucial information about a woman’s short-term risk of being diagnosed with breast cancer, so that they may further personalize her screening and surveillance plan. This may include screening frequency adjustment, supplemental imaging, genetic testing and/or risk reduction strategies. Ultimately, the goal of this technology is to enhance efficiency for clinicians and improve outcomes for patients.”Randy Hicks, MD, MBA., Radiologist, Co-owner & CEO of Regional Medical Imaging“ProFound AI Risk takes personalized breast cancer screening to the next level. It is efficient and easy-to-use. This first-in-kind technology seamlessly integrates into our workflow and offers a next-generation solution to stratify individual risk for our patients on the fly, with greater accuracy than traditionally used, hard to obtain and time-consuming risk models. It provides critical insights based off information garnered from 2D or 3D mammogram images, which helps the RMI team further personalize screening and surveillance plans for our patients.”Patrick Toubiana, MD, Radiologist, President and Co-Founder at the C.S.E. Centre Imagerie Médicale Numérique, Paris, France“We are proud to be the first private medical imaging center in France to benefit from iCAD’s latest solution, ProFound AI Risk. This innovative technology calculates the individual risk of breast cancer, from the analysis of information contained in the mammogram, such as density, texture, asymmetries and patient age, which is a much more precise approach than other risk models currently offered. This new algorithm allows us to identify women who are at higher risk of developing short-term breast cancer, and to personalize our follow-up for these women.”

PowerLook Density Assessment

Adrea Bennett,
Center for Women Supervisor, Swedish-American Hospital
“Installing PowerLook Density Assessment has helped improve the workflow of our department and also in the education of our patients about the importance of knowing your breast density.”
Angela Fried, MD,
Director of Breast Imaging, SimonMed Imaging
“We have had the AI density breast program for several years now and at the beginning there were some issues with radiologists not agreeing with what the determination was, but it has gotten very accurate, and our techs are able to take that information and plug it into the risk model without having to bother a radiologist to ask what density they should put. We are able to very quickly add that information to our reports and give that information to the patient and their physician to know if they should be coming in for additional screening. It’s something that give patients peace of mind when they have very dense breast tissue or to identify cancer earlier.”
Beth Ingram, MD,
Radiology, Interventional at
Reid Health
“Since implementing PowerLook Density Assessment, our radiologists have been able to provide more consistent breast density results for our patients during screenings. We must consider many aspects of each patient’s case at once, but PowerLook Density Assessment allows us to focus on our primary goal of finding breast cancer.”
Sue Jane Rivas Grosso, MD,
Lead Interpreting Physician at The American College of Radiology Mammography Accreditation Program at Summit Medical Group
“Since the New Jersey breast density law passed in 2014, both patients and physicians have become very aware of the issue of breast density. With PowerLook Density Assessment we can provide an automated method of determining breast density resulting in more accurate and objective results.”
Jason Stiver,
Radiology Department Manager at Punxsutawney Area Hospital
“PowerLook Density Assessment takes all the guess work out of determining breast density. If any other facility wants the most accurate and reliable software for its patients, look no further than PowerLook Density Assessment.”
Randy Hicks, MD, MBA., Radiologist, Co-owner & CEO of Regional Medical Imaging“Radiologist visual density assessment has suboptimal intra- and inter- observer agreement due to its visual, subjective assessment. This inconsistent reporting causes confusion, impacts patient care and derails referring physician and patient confidence. With PowerLook Density Assessment software, clinicians can feel confident in their patients’ density assessment. This solution is easy to integrate and implement, and is the ideal choice for those seeking to accurately automate density assessment and harmonize the patient experience.”

 

© iCAD Inc.  All rights reserved.  iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

Facebook icon Twitter icon LinkedIn icon